Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Blueprint Genetics Finland | 1 | 110 |
|
Ataxia, Comprehensive Evaluation Athena Diagnostics United States | 44 | 42 |
|
Ataxia, Complete Recessive Evaluation Athena Diagnostics United States | 21 | 18 |
|
Ataxia, Supplemental Recessive Evaluation Athena Diagnostics United States | 20 | 17 |
|
Asper Biogene Asper Biogene LLC Estonia | 180 | 139 |
|
CeGaT GmbH Germany | 1 | 1 |
|
Molecular Vision Laboratory United States | 372 | 283 |
|
Ataxia and differential diagnoses Panel CeGaT GmbH Germany | 173 | 204 |
|
Retinitis pigmentosa, autosomal recessive and X-linked Panel CeGaT GmbH Germany | 37 | 62 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Retinitis Pigmentosa NGS Panel Fulgent Genetics United States | 329 | 124 |
|
Comprehensive Eye Disorders NGS Panel Fulgent Genetics United States | 1018 | 459 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.